This ruling removes a major competitive barrier for EOFlow, which can now commercialize EOPatch 2 without the permanent injunction. For PODD holders, this increases competitive pressure in the insulin patch pump market and eliminates a significant IP victory. Monitor for EOFlow's market entry plans and any potential appeal by Insulet to the Supreme Court (unlikely given Federal Circuit's clear ruling on statute of limitations).
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 28 $141.98entry
- T+1 · 6mo ago +1.42%α +1.18% · $143.99
- T+5 · 6mo ago +0.93%α +0.97% · $143.30
- T+20 · 5mo ago +8.34%α +11.03% · $153.82
- T+60 · 3mo ago +4.18%α +2.71% · $147.92
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The Federal Circuit reversed the district court's judgment and permanent injunction against EOFlow, holding that Insulet's trade secret misappropriation claim under the Defend Trade Secrets Act was time-barred because Insulet knew or should have known of the misappropriation before August 3, 2020 (three years before filing suit). The court found undisputed evidence that Insulet had knowledge of EOFlow's access to its trade secrets through a former employee and of striking similarities between the Omnipod and EOPatch 2 by early 2019, triggering the three-year statute of limitations. This ruling vacates the $59.4 million in damages (after reduction) and the permanent injunction that barred EOFlow from commercializing products using Insulet's trade secrets, removing a major overhang on EOFlow's ability to compete in the insulin patch pump market.
Court Ruling Details
Key Facts
- Federal Circuit reversed district court's judgment and permanent injunction against EOFlow in Insulet's trade secret misappropriation case
- Court held Insulet's DTSA claim was time-barred because Insulet knew or should have known of misappropriation before August 3, 2020
- Jury had awarded $170M compensatory and $282M exemplary damages, later reduced to $25.8M compensatory and $33.6M exemplary to avoid double recovery with injunction
- Permanent injunction had barred EOFlow from commercializing products using Insulet's trade secrets worldwide
- Court applied access-plus-similarity framework: knowledge that former employee with trade secret access worked for competitor on similar product starts limitations clock
- Insulet had internal emails from March 2019 noting former employees worked on EOPatch 2, and employees described EOPatch 2 as 'cloned our product' after June 2018 ADA conference
- Dissenting opinion argued majority improperly substituted its fact-finding for the jury's and conflated discovery rule with inquiry-notice standard
Financial Impact
Vacated $59.4M in damages (after reduction) and permanent injunction; Insulet loses trade secret protection and competitive moat against EOFlow's EOPatch 2
Risk Factors
- Insulet may seek Supreme Court review, though certiorari is unlikely on a statute-of-limitations ruling
- EOFlow's EOPatch 2 could gain market share in Europe and South Korea, pressuring Omnipod sales
- Loss of trade secret protection may encourage other competitors to enter the patch pump market
- Insulet's patent claims were dismissed without prejudice but are likely time-barred, leaving no remaining IP claims against EOFlow
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-3ayo3elp-PODD |
Track record
11 reports on PODD
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry price pending
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $152.48 Now $145.29 −4.72% settles Feb 11
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $165.02 Now $145.29 −11.96% settles Feb 2
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $148.93 Now $145.29 −2.44% settles Jan 26
- Oct 23, 202624d ago Institutional Cluster Neutral 3/10 Entry $149.01 Now $145.29 −2.50% settles Jan 21
- Sep 21, 20268w ago 8-K Bullish 6/10 Entry $139.38 Now $145.29 +4.24% settles Dec 16
- Aug 5, 202614w ago 8-K Mixed 5/10 Entry $132.30 to $152.50 Now $145.29 +9.82% ▲ +15.26% +15.32% vs SPY
- Jul 24, 202616w ago Institutional Cluster Bearish 5/10 Entry $163.26 to $141.96 Now $145.29 +11.01% ▲ +13.05% +16.77% vs SPY
- May 28, 202624w ago Court Ruling Bearish 7/10 Viewing Entry $141.98 to $147.92 Now $145.29 −2.33% ▼ −4.18% −2.71% vs SPY
- May 6, 202627w ago 8-K Bullish 7/10 Entry $150.52 to $165.68 Now $145.29 −3.48% ▲ +10.07% +9.00% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers